Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0301-2115(02)00354-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Brain with coexistent acoustic schwannoma and ependymoma.
BMC Geriatr
January 2025
Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Background: This particular case is a world-first with no previous literature reports on patients presenting with both benign acoustic schwannoma and malignant ependymoma.
Case Presentation: A 60-year-old woman with unexplained right-sided hearing loss that had worsened progressively over 4 years, along with intermittent dizziness that had begun 3 years prior. Our preliminary diagnosis included: (1) Right acoustic neuroma; (2) Ependymoma of the fourth ventricle; and (3) Hydrocephalus.
Generation, manipulation, detection and biomedical applications of magnetic droplets in microfluidic chips.
Analyst
November 2024
The Fourth Hospital of Changsha, Changsha Hospital of Hunan Normal University, Changsha, 410006, People's Republic of China.
Microfluidic systems incorporating magnetic droplets have emerged as a focal point of significant interest within the biomedical domain. The allure of these systems lies in their capacity to offer precise control, enable contactless operation, and accommodate minimal sample concentration requirements. Such remarkable features serve to mitigate errors arising from human operation and other factors during cell or molecular detection.
View Article and Find Full Text PDFCharacterizing second line and beyond therapies for primary central nervous system lymphomas.
Hematol Oncol
November 2024
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Article Synopsis
- Primary central nervous system lymphoma (PCNSL) is a rare and aggressive cancer affecting the brain and spinal cord, typically treated with high-dose methotrexate (HDMTX) combined with other therapies, but many patients relapse after initial treatment.
- A study analyzed 54 adult PCNSL patients who received HDMTX-based treatment from 2016 to 2022, revealing that 57% underwent consolidation therapy, while 24% had autologous stem cell transplants.
- For those with relapsed or refractory (R/R) disease, treatments varied widely, including second and third line options like whole brain radiation (WBRT), clinical trials, and various combinations of rit
Circulating Gastric Cancer Stem Cells as Blood Screening and Prognosis Factor in Gastric Cancer.
Stem Cells Int
August 2024
Subdirección de Investigación Básica Instituto Nacional de Cancerología, Secretaría de Salud, Mexico City, Mexico.
Gastric cancer (GC) is the fourth leading cause of cancer-related death, associated with late diagnosis and treatment resistance. Currently, screening tests for GC are not cost-effective or have low accuracy. Previously, we described an extended phenotype of gastric cancer stem cells (GCSCs; CD24CD44CD54EpCAM) that is associated with metastasis and tumor stage in GC patients.
View Article and Find Full Text PDFProceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposium.
Sex Med Rev
September 2024
Chief Scientist and Director, Cardiovascular Research Institute, Huntington Medical Research Institutes, 686 S. Fair Oaks Ave., Pasadena, CA. 91105, United States.
Introduction: Prior consensus meetings have addressed the relationship between phosphodiesterase type 5 (PDE5) inhibition and cardiac health. Given significant accumulation of new data in the past decade, a fourth consensus conference on this topic was convened in Pasadena, California, on March 10 and 11, 2023.
Objectives: Our meeting aimed to update existing knowledge, assess current guidelines, and make recommendations for future research and practice in this area.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!